SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-024687
Filing Date
2018-10-23
Accepted
2018-10-23 07:31:38
Documents
46
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 ODT Q3 10-Q MASTER odt-10q_20180930.htm 10-Q 669120
2 EX-31.1 odt-ex311_6.htm EX-31.1 17013
3 EX-31.2 odt-ex312_7.htm EX-31.2 17018
4 EX-32.1 odt-ex321_8.htm EX-32.1 15208
  Complete submission text file 0001564590-18-024687.txt   2340900

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT odt-20180930.xml EX-101.INS 329462
6 XBRL TAXONOMY EXTENSION SCHEMA odt-20180930.xsd EX-101.SCH 28143
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE odt-20180930_cal.xml EX-101.CAL 21496
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE odt-20180930_def.xml EX-101.DEF 61619
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE odt-20180930_lab.xml EX-101.LAB 198731
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE odt-20180930_pre.xml EX-101.PRE 145333
Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 858-200-3830
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38318 | Film No.: 181133254
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences